 | Up a level |
Journal Article
Auner, Holger W., Iacobelli, Simona, Sbianchi, Giulia, Knol-Bout, Cora, Blaise, Didier, Russell, Nigel H., Apperley, Jane F., Pohlreich, David, Browne, Paul V., Kobbe, Guido, Isaksson, Cecilia, Lenhoff, Stig, Scheid, Christof, Touzeau, Cyrille 
ORCID: 0000-0003-0275-2575, Jantunen, Esa, Anagnostopoulos, Achilles ORCID: 0000-0003-4384-9031, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Tanase, Alina, Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Wiktor-Jedrzejczak, Wieslaw, Krejci, Marta, Schoenland, Stefan O., Morris, Curly, Garderet, Laurent and Kroeger, Nicolaus
(2018).
Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Haematologica, 103 (3).
S. 514 - 522.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078